A new drug darusentan is in clinical trails for patients with treatment resistant hypertention.The reasearch is funded by pharmacuetical company gliead.
For full details go to
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61500-2/fulltext
No comments:
Post a Comment